Cryoport Inc.
CYRX | NASDAQ
$17.62
+$0.60 (+3.53%)
At close: Sep 21, 2026, 4:00 PM ET
$17.81
+$0.19 (+1.08%)
Pre-market:
Sep 22, 2026, 7:52 AM ET
Company Profile
Cryoport, Inc. operates as a specialized service provider within the life sciences sector, delivering global temperature-controlled supply chain solutions across the Americas, Europe, the Middle East, Africa, and the Asia Pacific region. Central to their offerings is Cryoportal, a proprietary cloud-based platform designed to streamline the entire logistics process. This robust system facilitates order processing, generates necessary documentation (including customs paperwork), coordinates courier services, offers real-time shipment tracking and monitoring, aids in issue resolution, and ensures adherence to regulatory compliance standards. To guarantee the integrity of sensitive materials during transit, Cryoport provides CryoPort Express Shippers, engineered to maintain the stability of biological commodities throughout their journey. Furthermore, their SmartPak Condition Monitoring System collects vital environmental data, which is then utilized to produce informative dashboards and essential validation reports for each shipment. Their product range also includes specialized containment solutions such as vacuum insulated aluminum dewars and advanced cryogenic freezer systems. Beyond transportation, the company offers extensive biological specimen management services. These encompass cryopreservation storage and ongoing maintenance, meticulous archiving, continuous monitoring, precise tracking, and efficient receipt and delivery of samples. They also manage the transport of frozen biological specimens to and from client facilities and oversee the inbound and outbound flow of these critical materials. Additionally, Cryoport extends its expertise through comprehensive logistics support and management services, alongside short-term consulting in both logistics and engineering. The company primarily caters to the biopharmaceutical, animal health, and human reproductive medicine industries. Founded in 1999, Cryoport's headquarters are situated in Brentwood, Tennessee.
Key Executives
| Name | Position |
|---|---|
| Jerrell W. Shelton | Chairman, President & Chief Executive Officer |
| Phil Wilson | Chief Operating Officer of Cryoport Systems, LLC |
| Robert S. Stefanovich | Senior Vice President, Chief Financial Officer, Treasurer & Chief Administrative Officer |
| Edward J. Zecchini | Senior Vice President and Chief Digital & Technology Officer |
| Kylie A. Crowe | Vice President of Global Human Resources & Organizational Development |
| Mark W. Sawicki | Senior Vice President & Chief Scientific Officer |
| Thomas J. Heinzen | Vice President of Corporate Development & Investor Relations |
| Tony Ippolito | Vice President, General Counsel & Corporate Secretary |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Aug 14, 2026 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |
| Aug 13, 2026 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |
| Aug 11, 2026 | 4 | Filing |
| Aug 06, 2026 | 10-Q | Quarterly Report |
| Aug 06, 2026 | 8-K | Current Report |
| Jul 29, 2026 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |
| Jun 22, 2026 | S-8 | Filing |
| Jun 22, 2026 | 15-12G | Filing |
| Jun 12, 2026 | 4 | Filing |
| Jun 09, 2026 | 8-K | Current Report |
Cryoport Inc.
| Country | United States |
| IPO Date | Aug 21, 2005 |
| Industry | Integrated Freight & Logistics |
| Sector | Industrials |
| Employees | 688 |
| CEO | Jerrell W. Shelton |
Contact Details
112 Westwood Place Brentwood,
Tennessee 37027 United States
Stock Details
| Ticker Symbol | CYRX |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001124524 |
| CUSIP Number | 229050307 |
| ISIN Number | US2290503075 |
| SIC Code | 2834 |
Add to Watchlist
Select watchlists to add or remove CYRX